Access

You are not currently logged in.

Access JSTOR through your library or other institution:

login

Log in through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Journal Article

Inhibitors of the Cytochrome P-450 Enzymes Block the Secretagogue-Induced Release of Corticotropin in Mouse Pituitary Tumor Cells

Alberto G. Luini and Julius Axelrod
Proceedings of the National Academy of Sciences of the United States of America
Vol. 82, No. 4 (Feb. 15, 1985), pp. 1012-1014
Stable URL: http://www.jstor.org/stable/25153
Page Count: 3
Were these topics helpful?
See something inaccurate? Let us know!

Select the topics that are inaccurate.

  • Read Online (Free)
  • Subscribe ($19.50)
  • Add to My Lists
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Inhibitors of the Cytochrome P-450 Enzymes Block the Secretagogue-Induced Release of Corticotropin in Mouse Pituitary Tumor Cells
Preview not available

Abstract

A mouse pituitary tumor cell line (AtT-20) releases corticotropin (ACTH) in response to a number of secretagogues, including corticotropin-releasing factor (CRF), β -adrenergic agents, N6,O2′ -dibutyryladenosine 3′,5′-cyclic monophosphate (Bt2 cAMP), and potassium. The stimulation of ACTH secretion induced by the secretagogues can be blocked by inhibitors of the enzymes that generate (phospholipase A2) and metabolize (lipoxygenase and epoxygenase) arachidonic acid. The phospholipase A2 blockers mepacrine and p-bromophenacylbromide inhibited the ACTH release induced by secretagogues. The lipoxygenase inhibitors nordihydroguaieretic acid, butylated hydroxytoluene, and icosatetraynoic acid abolished the ACTH secretion induced by secretagogues, whereas indomethacin, a cycloxygenase inhibitor, did not. Blockers of the cytochrome P-450 epoxygenase, such as SKF 525A and piperonyl butoxide, compounds that have different molecular structures, also suppressed secretagogue-induced ACTH release. These findings suggest that metabolites of arachidonic acid formed via the epoxygenase and/or the lipoxygenase pathway are involved in the stimulation of ACTH release caused by secretagogues.

Page Thumbnails

  • Thumbnail: Page 
1012
    1012
  • Thumbnail: Page 
1013
    1013
  • Thumbnail: Page 
1014
    1014